Ann F. Mohrbacher , MD
Associate Professor of Clinical

Research Interests

My clinical research intercects focus on the basic immunology and immunotheraphy of leukemias, lymphomas, and multiple myeloma. I have performed trials of inter leukin 2, and monoclonal antibody therapies of these diseases. Translational laboratory research focuses on new fusion antibodies which combine immune stimulating molecules such as IL2 with the tumor targetting antibody.

Clinical Interests

Multiple myeloma
Lymphoma
Bone marrow transplant
Leukemias
Transfusion free (bloodless medicine)
Hematology

Degrees

Harvard Medical School, MD, 1983

Internships

Brigham and Women's Hospital, Boston, MA, 1983 - 1984

Residencies

Brigham and Women's Hospital, Boston, Massachusetts, 1984 - 1987

Fellowships

Dana Farber Cancer Institute, Boston, Massachusetts - Oncology, - 2000

Board Certification

American Board of Internal Medicine
Medical Oncology, 1993

Memberships

American Society of Hematology
American Society of Clinical Oncology

Clinical Affiliation

USC Care Medical Group
USC University Hospital
USC/Norris Cancer Hospital

Selected Publications

Mohrbacher A, Anderson KC: Bone marrow transplantation in multiple myeloma. In: Kyle R, Multiple myeloma. Oxford university press London 1994

Mohrbacher A, Jia L, Scheinber A, Epstein A, Douer D: Upregulation of B& and CD40L by IL2 and IL2 fusion antibodies in B cell malignancies. Blood 1998

Mohrbacher A, Justice G, Gregory S, Schultz M, Roberts L, Chen D, Giles FJ, Liposomal Daunorubicin is effective therapy for multiple lyeloma. Blood 1998

Mohrbacher A, Jia L, Epstein A, and Douer D: Cytokine and fusion antibody upregulation of fas on leukemias and fas meditated killing. Blood 90(10), suppl 1(part 1 of 2) 226 pg. 53a, 1997

Mohrabacher A, Xie S, Epstein A, Douer D: Augmented hepatopoiec progeneratior CFU-GM growth with co culture with novel monoclonal antibody (chCLL) against B cell HLA-DR epitope, and fusion protein derivatives with IL2 and GM-CSF. Blood 88, suppl 1 1996